SAINT-PRIEST, France--(BUSINESS WIRE)-- Regulatory News: JACQUET METALS (Paris:JCQ): Au 1er trimestre 2024, les conditions de marché ont été caractérisées par une demande faible sur tous les marchés du Groupe, entrainant une pression sur les prix et les marges brutes. La conjoncture du 2e trimestre s’inscrit dans la continuité de celle rencontrée en ce début d’année. Dans ces conditions, les ventes du Groupe s’élèvent à 558 millions d’euros, inférieures de 19,3 % à celles enregistrées un an auparavant et la marge brute représente 20,3 % du chiffre d’affaires contre 25 % au 1er trimestre ...
EQS-News: Dermapharm Holding SE / Key word(s): Quarterly / Interim Statement/Quarter Results Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy 15.05.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Strong organic growth in core marketsunderscores resilience of Dermapharm Holding SE's corporate strategy Robust, double-digit organic growth in high-margin "branded pharmaceuticals" largely offsets projected decline in vaccine production. Revenue in "Other healthcare prod...
EQS-News: Dermapharm Holding SE / Schlagwort(e): Quartals-/Zwischenmitteilung/Quartalsergebnis Dermapharm Holding SE unterstreicht mit einem starken organischen Wachstum in den Kernmärkten die Resilienz der Firmenstrategie 15.05.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Dermapharm Holding SE unterstreicht mit einem starken organischen Wachstum in den Kernmärkten die Resilienz der Firmenstrategie Starkes zweistelliges organisches Wachstum bei margenstarken „Markenarzneimitteln“ kompensiert mehrheitlich den geplan...
LONDON--(BUSINESS WIRE)-- BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces that AstraZeneca has added a novel target for Heart Failure to its discovery portfolio through its collaboration with BenevolentAI. Novel target for Heart Failure was discovered using BenevolentAI’s AI-drug discovery platform and experimentally validated by AstraZeneca First target to be selected from the extended collaboration with AstraZeneca, highlighting continued positive progress in the field of Target...
Programme de rachat d'actions propres - Déclaration des transactions sur actions propres réalisées du 6 mai 2024 au 10 mai 2024 Programme de rachat d’actions propres Déclaration des transactions sur actions propres réalisées du 6 mai 2024 au 10 mai 2024 Paris-La Défense, le 14 mai 2024 à 17h35, Conformément à la réglementation relative aux rachats d’actions, Assystem déclare ci-après les transactions sur actions propres réalisées du 6 mai 2024 au 10 mai 2024 : Présentation agrégée Nom de l'émetteurCode Identifiant de l'émetteurJour de la transactionCode identifiant de l'instrument fina...
We keep our BUY rating but lower our target price from €37.50 to €35.75 as we modestly reduce our estimates due to slightly lower membership ingrowth. 1Q24 update was more or less in line, although membership ingrowth was a notch behind but seems to some extent a phasing effect. Nevertheless, we remain cautious as the macro headwinds persist while the French ingrowth issues have not been solved yet. Positive, however, is that the issues are being addressed. Some other issues are still a work in ...
Titan Cement started off FY24 positively with Sales coming in at €623.7m, up 6.1% YoY, EBITDA rising 2.5% YoY to €109.8m and net profit clocking in at €52.5m, up 18.4% YoY. On the back of volume growth, firm pricing, improved operational efficiency and resilience of the US economy, mgmt. has issued a positive outlook for FY24. Also, the group continued to execute its growth-related investments, with €52.5m Capex. We view the results positively since Titan continues to executive with precision an...
Unifiedpost is a niche SaaS player in the e-invoicing and procurement channel space. Regulatory headwinds mean this market is ripe for growth, which should benefit Unifiedpost. Due to some unsuccessful past M&A, the company is in a challenging financial position today. However, it has recently embarked on a divestment path, aiming to streamline the business and improve its fundamentals. We like the new direction, however prefer to take a wait-and-see approach. - ...
Unifiedpost is a niche SaaS player in the e-invoicing and procurement channel space. Regulatory headwinds mean this market is ripe for growth, which should benefit Unifiedpost. Due to some unsuccessful past M&A, the company is in a challenging financial position today. However, it has recently embarked on a divestment path, aiming to streamline the business and improve its fundamentals. We like the new direction, however prefer to take a wait-and-see approach. - ...
>Q1 sales of € 1.7bn (vs € 1.9m est.) – EBITDA margin of 2.4% (vs 3%e) - For Q1 2024, Klöckner yesterday published earnings a shade below our estimates. Sales were down 5.6% at € 1,737m (vs € 1,900m est., consensus at € 1,804m) due to a negative price effect of 10.6%, with volumes posting an increase of +5%. The gross margin stood at € 297m representing 17% of sales, a slight increase of 20bp. However, EBITDA is down 35.4% at € 42m (vs € 60m est.), implying an EBITDA ...
>Solid Q1 24 results in a difficult environment - SAF-Holland’s Q1 24 reported group sales are +5% y-o-y to € 505m (-2% vs. ODDO BHF; -1% vs cons.) thanks to acquisition effects, while the organic growth rate is -8% y-o-y, due to the normalisation of the commercial vehicle market, particularly in the EMEA and Americas regions. The company’s group adj. EBIT is +12% y-o-y at € 48.6m (-1% vs ODDO BHF; in line with css) with a strong adj. EBIT margin of 9.6% (+10bp vs ODD...
>CA T1 de 1.7 Md€ (vs 1.9 Md€e) – Marge d’EBITDA de 2.4% (vs 3%e) - Au titre de son T1 2024, Klöckner a publié hier des résultats légèrement inférieurs à nos attentes. Le CA ressort en retrait de 5.6% à 1 737 M€ (vs 1 900 M€e, consensus à 1 804 M€) du fait d’un effet prix négatif de 10.6% alors que les volumes sont en hausse de +5%. La marge brute atteint 297 M€ représentant 17% du CA, soit une légère hausse de 20 pb. En revanche, l’EBITDA baisse de 35.4% à 42 M€ (vs ...
>Q1 EBITDA pre of € 101m in line with consensus of € 98m - Group sales declined by 15% y-o-y to € 1,607m (css € 1,578m) including volume decline by 5.4% y-o-y (Q4 23: -12% y/y) but up 13% q-o-q. Price erosion was 9.2% y-o-y and just -1% q-o-q. EBITDA pre of € 101m was in line with consensus/ODDO BHF estimates of € 98m and down 47% y-o-y on a high comparison base. EBITDA pre regained slightly from € 97m in Q4 2023. Activity pick-up throughout Q1 pushed receivables, wei...
EQS-News: SAF-HOLLAND SE / Key word(s): Quarterly / Interim Statement/Quarter Results SAF-HOLLAND with a solid start to fiscal year 2024: Adjusted EBIT margin significantly improved to 9.6 per cent in the first quarter – full-year guidance confirmed 08.05.2024 / 07:01 CET/CEST The issuer is solely responsible for the content of this announcement. SAF-HOLLAND with a solid start to fiscal year 2024: Adjusted EBIT margin significantly improved to 9.6% in the first quarter – full-year guidance confirmed Group sales increase by 5.2% to EUR 505.4 million (previous year: E...
EQS-News: SAF-HOLLAND SE / Schlagwort(e): Quartals-/Zwischenmitteilung/Quartalsergebnis SAF-HOLLAND mit solidem Start in das Geschäftsjahr 2024: Bereinigte EBIT-Marge im 1. Quartal auf 9,6 Prozent deutlich verbessert – Jahresprognose bestätigt 08.05.2024 / 07:01 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. SAF-HOLLAND mit solidem Start in das Geschäftsjahr 2024: Bereinigte EBIT-Marge im 1. Quartal auf 9,6 Prozent deutlich verbessert – Jahresprognose bestätigt Konzernumsatz steigt um 5,2 % auf 505,4 Mio. Euro (Vorjahr 480,4 M...
ORGON, France--(BUSINESS WIRE)-- Regulatory News: ID Logistics (Paris:IDL) : Les actionnaires de la société sont avisés que l’Assemblée Générale Mixte de la société se tiendra en présentiel le 30 mai 2024, à 14h au siège social de la société : 55 chemin des Engrenauds - 13660 Orgon. L’avis préalable comportant l’ordre du jour et les projets de résolutions a été publié au BALO du 24 avril 2024 et l’avis de convocation sera publié au BALO du 15 mai 2024 et dans un journal d’annonces légales du même jour. Les documents préparatoires à l’Assemblée énoncés par l’article R. 22-10-23 du Code ...
>Q1 2024 earnings are ahead of expectations - Schaeffler’s reported Q1 2024 group sales are -2% y-o-y to € 4.09bn, which is a touch below our expectation (ODDO BHF: € 4.11bn) and consensus (€ 4.13bn). Sales in Auto Tech division are +0.8% organically, Vehicle Lifetime Solutions (previously Automotive Aftermarket) sales are +8.6% organically and sales in Bearings& Industrial Solutions are -4.1% y-o-y. By region, sales in Europe are -0.4% organically, +4.2% in the Ameri...
EQS-News: Schaeffler AG / Schlagwort(e): Quartalsergebnis Schaeffler startet gut ins neue Geschäftsjahr 07.05.2024 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Schaeffler startet gut ins neue Geschäftsjahr Umsatz währungsbereinigt mit 4,1 Milliarden Euro und EBIT-Marge vor Sondereffekten mit 7,9 Prozent auf Vorjahresniveau Free Cash Flow vor Ein- und Auszahlungen für M&A-Aktivitäten saisonal bedingt bei minus 166 Millionen Euro (Vorjahr: minus 73 Millionen Euro) Automotive Technologies mit positiver Entwicklung, Vehicl...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.